Differential integrin expression by T lymphocytes: Potential role in DMD muscle damage-Reference-Cited by-同舟云学术

Differential integrin expression by T lymphocytes: Potential role in DMD muscle damage

Published:2010-06 Issue:1-2 Volume:223 Page:128-130
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Pinto-Mariz Fernanda,Rodrigues Carvalho Luciana,de Mello Wallace,de Queiroz Campos Araújo Alexandra,Gonçalves Ribeiro Márcia,do Carmo Soares Alves Cunha Maria,Voit Thomas,Butler-Browne Gillian,Silva-Barbosa Suse Dayse,Savino Wilson

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology,Immunology,Immunology and Allergy

Reference16 articles.

1. The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies;Banks;Curr. Top. Dev. Biol.,2008

2. Interstitial leukocyte migration and immune function;Friedl;Nat. Immunol.,2008

3. Specific T cell receptor gene rearrangements at the site of muscle degeneration in Duchenne muscular dystrophy;Gussoni;J. Immunol.,1994

4. The effects of glucocorticoid therapy on the inflammatory and dendritic cells in muscular dystrophies;Hussein;Int. J. Exp. Pathol.,2006

5. Mononuclear cell analysis of muscle biopsies in prednisone-treated and untreated Duchenne muscular dystrophy;Kissel;Neurology,1991

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase 2 open-label study of the safety and efficacy of weekly dosing of ATL1102 in patients with non-ambulatory Duchenne muscular dystrophy and pharmacology in mdx mice;PLOS ONE;2024-01-25

2. Histological Methods to Assess Skeletal Muscle Degeneration and Regeneration in Duchenne Muscular Dystrophy;International Journal of Molecular Sciences;2022-12-16

3. A Spotlight on T Lymphocytes in Duchenne Muscular Dystrophy—Not Just a Muscle Defect;Biomedicines;2022-02-24

4. A Phase 2 open-label study to determine the safety and efficacy of weekly dosing of ATL1102 in patients with non-ambulatory Duchenne muscular dystrophy;2022-01-19

5. Benefits and pathologies associated with the inflammatory response;Experimental Cell Research;2021-12